Transthyretin Cardiac Amyloidosis Fellowship Grant

Transthyretin Cardiac Amyloidosis Fellowship Grant

Status: ACTIVE
Funder: Pfizer, Inc.
Amount: Up to US $80,000
Last Updated: April 02, 2025

Summary

The Transthyretin Cardiac Amyloidosis Fellowship, supported by Pfizer, Inc., aims to enhance training for healthcare professionals in recognizing and managing ATTR cardiac amyloidosis. This competitive program focuses on clinical practice, research, and education, fostering a deeper understanding of the condition. It specifically targets fellowship programs for Cardiologists and Advanced Practice Providers in Heart Failure, ensuring a strong emphasis on advancing knowledge and care in this critical area of cardiology.

Overview

About This competitive program seeks to promote the importance of training healthcare professionals to recognize, diagnose and manage ATTR cardiac amyloidosis and to foster research in this field. Project Types and Area of Interest It is our intent to support institutions with fellowship programs for Cardiologists or Heart Failure Advanced Practice Providers that have a strong focus on clinical practice, research, and education to further the understanding of ATTR cardiac amyloidosis.

Eligibility

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Application Details

Pfizer Fellowship Grant Request for
Proposals
Competitive Grant Program – using Expert Review Panel
Transthyretin Cardiac Amyloidosis Fellowship-
United States
Overview
This competitive program seeks to promote the importance of training
healthcare professionals to recognize, diagnose and manage ATTR
cardiac amyloidosis and to foster research in this field.
Geographic Scope
United States
Project Types and Area of Interest
It is our intent to support institutions with fellowship programs for
Cardiologists or Heart Failure Advanced Practice Providers that have a
strong focus on clinical practice, research, and education to further the
understanding of ATTR cardiac amyloidosis.
Key Milestones
Anticipated Grant Anticipated Project
Submission Deadline Award Notification Duration
June 20, 2025 September 2025 July 2026-June 2027
Funding Range and Project Length
Grant funding is available to support one fellow for up to a year at
$80,000 USD.

I. Eligibility
Geographic Scope
• United States
Applicant Eligibility Criteria
• Accredited, US-based academic institution.
• Do not include the name of the potential fellow(s) in application materials. This grant will be awarded
to an institution, not an individual.
• Institutions with fellowship programs that include independent research and a strong mentoring
program. Clinical training may be included in the program but is not required.
• No aspect of the fellowship program can benefit Pfizer’s business or a Pfizer asset.
• Examples of independent research include: observational studies and outcomes research studies
where the primary focus is the scientific understanding of disease; use of screening tools and their
impact on improvement of patient health.
• Examples of research that would not be eligible include research involving the study and/or
evaluation of any pharmaceutical product and basic science and/or fundamental research (in animal
model, in-vitro, etc.).
• Examples of clinical training include: educational time with an interdisciplinary team in review of case
examples and relevant didactic training as well as use of tools for improvement in patient health for
specific therapeutic areas or conditions.
• Fellow time spent in the clinical setting that is supported through grant funds must not be billed as
patient care.
II. Requirements
Specific Area of Interest for this RFP:
• It is our intent to support institutions with fellowship programs for Cardiologists or Heart Failure
Advanced Practice Providers that have a strong focus on clinical practice, research, and education to
further the understanding of ATTR cardiac amyloidosis.
• Proposals from both established and emerging fellowships will be considered. Preference will be
given to programs which have not been selected in the last 3 years or states with underserved
populations.
Requirements for Prospective Fellows:
• Institution must ensure that any fellow that will receive grant funds must be a U.S. Worker (U.S.
citizen, permanent resident, refugee, or asylee), or hold an appropriate non-immigrant visa status
authorizing employment in the U.S.
• U.S. Physician Payments Sunshine Act (“Sunshine Act”) and other transparency law requirements must
be satisfied with respect to meals, payments and other transfers of value. As a condition of the grant,
the selected fellow will be named in transparency reporting as a recipient of grant funding.
Budget
• Grant funding is available to support one fellow for up to a year at $80,000 USD. The budget can only
include salary and support of the fellow benefits.
• Grant funds cannot be used for overhead or indirect costs.
• Funding will be awarded to the institution, not an individual.
• Fellow time spent in the clinical setting that is supported through grant funds must not be billed as
patient care.
• No aspect of the fellowship program budget can reflect a benefit to Pfizer’s business or a Pfizer asset.
2

Timeline
Anticipated Grant Anticipated Project
RFP Release Date Award Notification End Date/Duration
February 19, 2025 September 2025 June 2027
Submission Deadline* Anticipated Project
Start Date
June 20, 2025
July 2026
IMPORTANT: Be advised applications submitted after the due date will not be reviewed.
*Please note the deadline is 23:59 Eastern Standard Time (e.g., New York, GMT -5)
III. Submissions
How to Submit
IMPORTANT: Please read this section carefully since applications submitted not following these
instructions will not be accepted and will be cancelled.
• Please go to www.cybergrants.com/pfizer/GMGFellowship and sign in.
• Note: there are individual portals for each grant application type. Please be sure to use the
URL above.
• First-time users should click “Create your password”.
• Click the "Start A New Fellowship Application" button.
• Requirements for submission:
• Complete all required sections of the online application
• IMPORTANT: Upload Proposal using the required Proposal Template - Click here
• In the application:
• For the question “Competitive Grant?” select “Yes”
• Select the following Primary Area of Interest: CVM- ATTR-CM
• Select the following Competitive Grant Program Name:
2025 RD US Cardiac Amyloidosis Fellowship
Questions
• If you encounter any technical difficulties with the website, please click here or the “Technical
Questions” link at the bottom of the page in the grant system.
• Please click here to view “Frequently Asked Questions” regarding the Competitive Grant Program.
• If you have questions regarding this RFP, please direct them in writing to the Grant Officer, Amanda
Stein (amanda.j.stein@pfizer.com), with the subject line, “US Cardiac Amyloidosis Fellowship.”
3

Review and Approval Process
• A specific grant program RFP uses an expert review panel (ERP) to make final grant decisions.
• The panels are comprised of professionals from the medical community with advanced degrees and
expertise in particular clinical areas, or specific needs of a geographic region/learner group, or
expertise in research, continuing professional development or quality improvement.
• Proposals will be evaluated based on the following evaluation criteria: fellowship goals, objectives,
medical needs and population health, patient care experience, program criteria, mentoring, training
opportunities, and resources.
Mechanism by which Applicants will be Notified:
• All applicants will be notified via email by the dates noted above.
• Applicants may be asked for additional clarification during the review period.
About Pfizer Global Medical Grants & Partnerships
Pfizer Global Medical Grants & Partnerships (GMGP) supports the global healthcare community’s
independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes
in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMGP competitive grant program involves a publicly posted Request for Proposal (RFP) that
provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an
expert review panel (ERP). Institutions are invited to submit an application as outlined in the specific RFP.
This RFP reflects Pfizer’s commitment to advancing research, innovation, and training for medical,
nursing, and allied health professionals.
4

Appendix
IMPORTANT: RFP Submission Requirements
Please click here to download a Proposal Template which includes the fields listed below (Institutions
may also utilize their own format but must address all areas noted below). This document should be
formatted with single-spaced using 12-point font and 1-inch margins and should not exceed 10-15
pages.
Cover Page (not to exceed 1 page)
• Title: Please include the fellowship title, and main institutions
• Abstract: Please include an abstract summary of your proposal including the goal of the fellowship,
methods the institution uses to support the fellow’s training and research, and assessment.
Overall Goals and Objectives of the Fellowship
• Describe the overall goal of the fellowship.
• Describe the focus of research and/or clinical training as applicable that is being supported in
general terms based on the categorizations listed in this application.
Methods
• Please describe the mentoring process.
• Include a description of the methods used to support the fellow and their research and/or clinical
training. (e.g. details on research training opportunities, how will they will develop their skills?)
• Please describe how the Fellowship supports diversity, equity, and inclusion either through the
Fellow being selected or through the mentoring team that is directly involved
Resources
• Please describe the institution’s academic, clinical training, and research capacity.
• Describe the facilities/resources that are made available to the fellow.
• Provide a summary of relevant past work that is applicable.
Challenges
• Please provide a summary of potential challenges and of plans for addressing those challenges.
Institutional Support
• Division Head/ Department Chair Letter of Support.
• Primary mentor; Secondary mentor (if applicable) Letter of Support
Budget
• Budget: Address any additional sources of financial support for this proposal, including current and
pending sources of funding
• Any request for funds beyond salary support will not be provided as part of the award
Anticipated Project Timeline
• Provide an anticipated timeline for your project including project start/end dates.
Additional Information
• If there is any additional information you feel Pfizer should be aware of concerning the importance
of this project, please summarize here
5